Medicare Enrolled

Dr. Steven Rosenblatt, M.D.

Nephrology · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4511 NW LOOP 410 STE 104, San Antonio, TX 78229
2106147900
In practice since 2005 (20 years)
NPI: 1710962279 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosenblatt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenblatt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosenblatt

Dr. Steven Rosenblatt is a nephrology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rosenblatt performed 314 Medicare services across 201 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rosenblatt received a total of $4,792 from 26 pharmaceutical and/or device companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosenblatt is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 314 Medicare services $4,792 industry payments

Medicare Practice Summary

Medicare Utilization ↗
314
Medicare services
Bottom 13% in TX for nephrology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
201
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~16 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 193 $67 $364
Office visit, established patient (20-29 min) 66 $55 $257
Office visit, established patient, complex (40-54 min) 22 $100 $510
New patient office visit (45-59 min) 19 $123 $474
Complete ultrasound scan behind abdominal cavity 14 $75 $331
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,792
Total received (2018-2024)
Avg $685/year across 7 years
Top 21% in TX for nephrology
26
Companies
151
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,756 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$36 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,206
2023
$1,191
2022
$609
2021
$616
2020
$116
2019
$491
2018
$564

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
OPKO Pharmaceuticals, LLC
$1,243
AstraZeneca Pharmaceuticals LP
$839
GlaxoSmithKline, LLC.
$278
Amgen Inc.
$264
Bayer Healthcare Pharmaceuticals Inc.
$241
Novartis Pharmaceuticals Corporation
$218
Horizon Therapeutics plc
$185
Otsuka America Pharmaceutical, Inc.
$163
Travere Therapeutics, Inc.
$153
AKEBIA THERAPEUTICS INC
$148
Mallinckrodt Enterprises LLC
$144
Novo Nordisk Inc
$137
Mallinckrodt Hospital Products Inc.
$132
Mallinckrodt LLC
$118
Advanced Accelerator Applications
$109
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
NxStage Medical, Inc.
$69
CorMedix Inc.
$48
Lilly USA, LLC
$44
Otsuka Pharmaceutical Development & Commercialization, Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$34
Ardelyx, Inc.
$25
Amicus Therapeutics, Inc.
$24
Fresenius USA Marketing, Inc.
$19
Alexion Pharmaceuticals, Inc.
$16
Ultragenyx Pharmaceutical Inc.
$14
Top 3 companies account for 49.3% of total payments
Associated products mentioned in payments ›
ACTHAR · Auryxia · BENLYSTA · CRYSVITA · DefenCath · ENTRESTO · FARXIGA · Fabhalta · IBSRELA · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUTATHERA · Ozempic · Parsabiv · RAYALDEE · Rayaldee · SAMSCA · SYSTEM ONE · TAVNEOS · TERLIVAZ · TRADJENTA · Ultomiris · Vafseo · Velphoro
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $1,526 per 100 Medicare services performed
Looking for a nephrology specialist in San Antonio?
Compare nephrologists in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
101
Per 100K population
5.0
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rosenblatt is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rosenblatt experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rosenblatt performed 193 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosenblatt receive payments from pharmaceutical companies?
Yes. Dr. Rosenblatt received a total of $4,792 from 26 companies across 151 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosenblatt's costs compare to other nephrologists in San Antonio?
Dr. Rosenblatt's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosenblatt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in San Antonio
Browse nephrologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in TX
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in TX
Which TX nephrologists receive the most from drug and device companies.
By company
OPKO Pharmaceuticals, LLC Payments to Doctors
See all physicians who received payments from OPKO Pharmaceuticals, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →